Home LiteratureArticle Details
PMID: 1939785 Published · ppublish English Journal Article

Analysis of HMB-45 immunoreactivity in common and cellular blue nevi.

Journal of cutaneous pathology ·Vol. 18 ·No. 4 ·1991-08-00 ·Pages 261-3

Wood WS, Tron VA

Abstract

HMB-45 is generally thought of as a melanoma specific antibody; however, there are certain exceptions. It is known that most dermal nevi show no reactivity; however, the dermal nevus component within dysplastic nevi and certain Spitz nevi show positive reactivity. In order to further examine this observation, we undertook a study to examine blue nevi, both common and cellular, for the expression of HMB-45. Cases were stained with antibodies directed at both HMB-45 and S100 protein. Of 16 common blue nevi studied, 14 were positive with HMB-45, as were 6 of 6 cellular blue nevi. Staining for HMB-45 was quite variable in intensity amongst cases labelled common blue nevi. In contrast, cellular blue nevi were uniformly strongly positive. It is therefore concluded that blue nevi, including cellular blue nevi, exhibit an activated phenotype as demonstrated by HMB-45 reactivity.

MeSH Terms
Antibodies, Monoclonal/immunology Humans Immunohistochemistry Nevus, Pigmented/chemistry,immunology,pathology Phenotype S100 Proteins/chemistry,immunology Skin Neoplasms/chemistry,immunology,pathology
Chemicals
Antibodies, Monoclonal S100 Proteins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Wood W S
Department of Pathology, University of British Columbia, Canada.
Tron V A
Article Info
Journal
Journal of cutaneous pathology
Abbr.
J Cutan Pathol
ISSN
0303-6987
Published
1991-08-00
Pages
261-3
Language
English
Region
United States
NLM ID
0425124
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]